BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6322797)

  • 1. Effect of omeprazole on gastric secretion in H+,K+-ATPase and in pepsinogen-rich cell fractions from rabbit gastric mucosa.
    Fryklund J; Wallmark B; Larsson H; Helander HF
    Biochem Pharmacol; 1984 Jan; 33(2):273-80. PubMed ID: 6322797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric acid secretion.
    Wallmark B; Jaresten BM; Larsson H; Ryberg B; Brändström A; Fellenius E
    Am J Physiol; 1983 Jul; 245(1):G64-71. PubMed ID: 6307064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
    Fellenius E; Berglindh T; Sachs G; Olbe L; Elander B; Sjöstrand SE; Wallmark B
    Nature; 1981 Mar; 290(5802):159-61. PubMed ID: 6259537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.
    Elander B; Fellenius E; Leth R; Olbe L; Wallmark B
    Scand J Gastroenterol; 1986 Apr; 21(3):268-72. PubMed ID: 3012768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibition--the ultimate control of acid secretion?
    Zdon MJ; Ballantyne GH; Schafer DE; Tyshkov M; Cambria RP; Modlin IM
    J Surg Res; 1986 Apr; 40(4):353-61. PubMed ID: 2422442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of omeprazole on the synthesis and secretion of pepsinogen in isolated rabbit gastric glands.
    Défize J; Pals G; Frants RR; Westerveld BD; Festen HP; Pronk JC; Meuwissen SG; Eriksson AW
    Biochem Pharmacol; 1985 Oct; 34(20):3693-9. PubMed ID: 2996557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling of H(+)-K(+)-ATPase activity and glucose oxidation in gastric glands.
    Fryklund J; Gedda K; Scott D; Sachs G; Wallmark B
    Am J Physiol; 1990 May; 258(5 Pt 1):G719-27. PubMed ID: 2159239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological agents of gastric acid secretion: receptor antagonists and pump inhibitors.
    Wallmark B; Fryklund J
    Methods Enzymol; 1990; 191():721-38. PubMed ID: 1963658
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of action of omeprazole.
    Wallmark B
    Scand J Gastroenterol Suppl; 1986; 118():11-7. PubMed ID: 3014640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
    Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
    Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
    Nishioka K; Nagao T; Urushidani T
    Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.
    Fujisaki H; Shibata H; Oketani K; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Yamaguchi M; Sakai H; Takeguchi N
    Biochem Pharmacol; 1991 Jul; 42(2):321-8. PubMed ID: 1650210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of omeprazole and famotidine on (H+-K+) ATPase and acid secretion in rabbit gastric glands].
    Tomoi M; Itoh H; Ueda S; Ono T; Shibayama F
    Nihon Yakurigaku Zasshi; 1988 Aug; 92(2):105-11. PubMed ID: 2852155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of acid secretion in isolated gastric glands by substituted benzimidazoles.
    Fellenius E; Elander B; Wallmark B; Helander HF; Berglindh T
    Am J Physiol; 1982 Dec; 243(6):G505-10. PubMed ID: 6293317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific labelling of gastric H+,K+-ATPase by omeprazole.
    Fryklund J; Gedda K; Wallmark B
    Biochem Pharmacol; 1988 Jul; 37(13):2543-9. PubMed ID: 2839196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfide and sulfoxide derivatives of substituted benzimidazoles inhibit acid formation in isolated gastric glands by different mechanisms.
    Fryklund J; Wallmark B
    J Pharmacol Exp Ther; 1986 Jan; 236(1):248-53. PubMed ID: 3001289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell.
    Wallmark B; Brändström A; Larsson H
    Biochim Biophys Acta; 1984 Dec; 778(3):549-58. PubMed ID: 6095911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pepsinogen synthesis and secretion in isolated gastric glands.
    Défize J; Pals G; Frants RR; Westerveld BD; Meuwissen SG; Erkisson AW
    J Clin Pathol; 1984 May; 37(5):531-6. PubMed ID: 6327774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.